Darron R. Brown

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

Laura A. Koutsky, Kevin A. Ault, Cosette M. Wheeler et al. · New England Journal of Medicine · 2002 · 1.6K citations · Full text

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · The Lancet Oncology · 2005 · 1.6K citations

Vaccination, Vaccinology, Vaccine Development +9

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

Darron R. Brown, Susanne K. Kjær, Kristján Sigurðsson et al. · The Journal of Infectious Diseases · 2009 · 627 citations · Full text

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

Nubia Muñóz, Susanne K. Kjær, Kristján Sigurðsson et al. · JNCI Journal of the National Cancer Institute · 2010 · 562 citations · Full text

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

Luisa L. Villa, Kevin A. Ault, Anna R. Giuliano et al. · Vaccine · 2006 · 465 citations

Vaccination, Vaccine Development, Human Papillomavirus Vaccines +9